作者: Shoichi Kinugasa , Shun’ichi Abe , Mitsuo Tachibana , Yoshitaka Hishikawa , Hiroshi Yoshimura
DOI: 10.1159/000011916
关键词: Stomach 、 Immunohistochemistry 、 Log-rank test 、 Transforming growth factor 、 Pathology 、 Internal medicine 、 Survival analysis 、 Adenocarcinoma 、 Gastroenterology 、 Survival rate 、 Proliferating cell nuclear antigen 、 Biology
摘要: A retrospective study of 50 patients with scirrhous carcinoma the stomach who had undergone surgery was performed to elucidate whether immunohistochemical overexpression transforming growth factor-beta1 (TGF-beta1) could predict patients' survival. To evaluate proliferative activity tumor, proliferating cell nuclear antigen (PCNA) index used. Expression TGF-beta1 low in 27 and high 23. Clinicopathological characteristics were not significantly different between two groups expression. Tumors higher expression PCNA indices (p = 0.0467, unpaired Student's t test). The 5-year survival rate 40.4% for group 28.7% 0.0388, log rank By multivariate analysis, pT, residual independent prognostic factors. These results suggest that is one useful predictors estimating particularly T3 T4 stages.